Title : Development of a process to manufacture PEGylated orally bioavailable insulin.

Pub. Date : 2010 Nov-Dec

PMID : 20949602






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The attachment of PEG to insulin resulted in a conjugated insulin derivative that was biologically active, orally bioavailable and that showed a dose-dependent glucose lowering effect in Type 2 diabetes patients. Polyethylene Glycols insulin Homo sapiens
2 The attachment of PEG to insulin resulted in a conjugated insulin derivative that was biologically active, orally bioavailable and that showed a dose-dependent glucose lowering effect in Type 2 diabetes patients. Polyethylene Glycols insulin Homo sapiens